2020, ended June 30, 2020 The operating results of the Company and its subsidiaries for the second quarter of 2020, ended June 30, 2020 was described in the financial statement showing net loss at the

medical services 121.38 117.29 104.77 4.08 3.48 16.60 15.85 340.79 286.49 54.29 18.95 Cost of services 112.06 107.97 100.54 4.09 3.79 11.52 11.46 319.63 289.14 30.49 10.55 Gross profit (loss) 9.31 9.33 4.23

Analysis Quarter 3 Ending 30 September 2018 Highlights Q3/2018, the Company and subsidiary’s total net loss equals Baht 431 million, net loss decreased by Baht 970 million or 69% QoQ. Total revenue from

. However, the Company still has retained deficit within 5 years from the loss year (As at June 30, 2017, the balance was 41 million Baht) Such loss, according to Thai Accounting standard No.12, requires the

Analysis Quarter 2 Ending 30 June 2018 Highlights Q2/2018, the Company and subsidiary’s total net loss equals Baht 1,401 million comparing with previous quarter which has net profit Baht 495 million. Total

of 2019 was equivalent to -16.47 times whereas 3.18 time of 2018. The deficit ratio came from the decrease of equity due to loss from operation since 2018 to 2019. Shareholders’ Equity As ended

Analysis Yearly Ending 31 December 2018 Highlights In 2018, the Company and subsidiary’s total net loss equals Baht 2,358 million comparing with last year which has net profit Baht 366 million. Separate

Analysis Quarter 2 Ending 30 June 2019 Highlights Q2/2019, the Company and subsidiary’s total net loss equals Baht 223 million, loss decreased by Baht 1,178 million or 84% comparing with same period of last

Loss Before Income Tax -303.53 -57.17 -246.36 -430.93 Income tax expense 11.10 -2.43 13.53 -556.79 Total loss for the period -292.43 -59.60 -232.83 -390.65 Other Comprehensive Income -4.78 1.02 -5.8

Analysis Quarter 1 Ending 31 March 2019 Highlights Q1/2019, the Company and subsidiary’s total net loss equals Baht 803 million, decreased by Baht 1,298 million or 262% comparing with same period of last